Tag: Healthcare
Allen & Gledhill appoints head of China practice
Allen & Gledhill appoints Wang Xin partner to lead China practice in Shanghai, strengthening M&A
Allen & Gledhill launches two new practices in Singapore
Allen & Gledhill establishes two new practices – technology disputes, and healthcare, life sciences and pharmaceuticals
CAM, Argus act on Bessemer’s USD31m Sukino investment
Firms advise on Bessemer Venture Partners’ USD31 million investment in India-based Sukino Healthcare
Partner compliance and trade secret protection in the AI era
This article focuses on two areas, third party governance and trade secret protection, setting out the key shifts and compliance priorities driven by AI
M&A: A new way
As M&A activities climb across the region, rising regulatory complexity and shifting market dynamics are redefining strategy, execution and the evolving role of general counsel
White & Case adds partner from KWM to boost M&A practice
White & Case has hired Alex Elser as a partner in Sydney to strengthen its global M&A practice, private capital industry group
LPA’s Lanvers-Shah sees cross-border activity uptick in India
Lisbeth Lanvers-Shah, the newly appointed head of the India desk and of counsel at LPA Singapore, believes India is poised for increased cross-border activity across multiple sectors
Private equity partner rejoins Weil in Hong Kong
Weil welcomed back private equity expert Yu Peng as a partner in its Hong Kong office, where he had previously practised for three years
The A-List 2025-26: Growth Drivers
Growth Drivers: We highlight leading Chinese and international lawyers who excel across legal and business sectors
Japan In-House Counsel Network announces new leadership?
The Japan In-House Counsel Network (JICN) has appointed Novo Nordisk general counsel Akiko Kikuchi as its new co-president to lead alongside Angela Yuen
Healthcare M&A in India – What’s driving deals?
Regulation reshapes India healthcare M&A: Structuring deals for compliant, scalable and sustainable investment growth
Hospital deals: Terms behind the headlines
Mitigating hidden regulatory, tax, property and liability risks in 含羞草社区 hospital sector investments
Ashwin Sapra leaves CAM, joins Trilegal as equity partner
Ashwin Sapra joins Trilegal as equity partner, strengthening its healthcare and life sciences practice
Opportunities in Japan’s regenerative medicine, gene therapy markets
Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations
Thomson Geer grows employment team, adds partner in Melbourne
Thomson Geer has appointed Jane Hall as a partner in Melbourne to strengthen its national employment and workplace safety team
Global Law Office adds pharmaceuticals and financing trio
Global Law Office has recently hired three lawyers to strengthen its life sciences and financing practice
Firms assist on PVP Ventures’ INR1.8bn in healthcare deals
PVP Ventures makes INR1.82b healthcare acquisitions advised by multiple law firms
Firms act on ABC Impact’s first stake in Philippine health
AC Health acquired a 16% stake in ABC Impact, with legal advice from Milbank and Sidley Austin
Isshiki boosts IP with ex-Novartis Japan GC’s partner hire
Isshiki & Partners has strengthened its IP practice with the partner hire of Hiromi Furushima
Healthcare and life science regulation in Japan
Japan is easing restrictions on medical data under two key laws as it focuses on promoting the use of this information
Baker McKenzie FenXun hires 4 Wilson Sonsini experts in China
Baker McKenzie FenXun hires four Wilson Sonsini experts for its Greater China team
Quartet acts on USD298m Rasmeli buy in Apollo Healthco
SAM, AZB & Partners, CAM, and Ropes & Gray advised on a complex deal for Rasmeli's investment in Apollo Healthco, a subsidiary of Apollo Hospitals
KICA merges law, leisure and learning in Seoul
The Korea In-house Counsel Association (KICA) held its annual workshop at Paraspara Seoul from 4-5 October
Tahota breaks into northeast China with first Harbin branch
Tahota Law Firm opens first northeast China branch in Harbin, expanding influence to Russia and northeast Asia
How can pharmas amid VBP reform ‘make elephants dance’?
Volume-based procurement (VBP) of drugs and medical supplies has become the new normal in China’s medical sector






























































